Global Leukemia Therapeutics Market Report By Therapy (Chemotherapy, Biological Therapy, Radiation Therapy, Targeted Therapy, And Other), Type (Chronic Leukemia, Chronic Lymphatic Leukemia, Chronic Myeloid Leukemia, Acute Leukemia, Acute Lymphatic Leukemia, Acute Myeloid Leukemia, And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11210140
January 2020
Report Formats:

Increased prevalence of cancer especially blood cancer across the world leading to rising demand for effective treatments is the driving market growth. Rise in expenditure on development of novel treatment and developing health infrastructure is further fueling the market growth. Additionally, the rise in survival rate and minimum side effects of novel treatment such as stem cell therapy, bone marrow transplant has open new avenues for the market growth. Furthermore, increasingly exposed to chemical mutation, changing dietary habits and living style of the population is further pushing the market growth.

The latest report by Value Market Research expects the Global Leukemia Therapeutics Market accounted for USD 10 billion and is expected to reach USD 12.5 billion at CAGR of 4% from the year 2017 to 2024.
 
ACUTE LEUKEMIA EMERGED AS THE LEADING THE SEGMENT
In 2017, acute leukemia is dominating the segment and has accounted for maximum market share. Owing to the growing condition of cancerous cells, acute leukemia is driving the segment growth. Rising smoking habits, exposure to chemicals, radiations and cases with other blood-related disorders are again fueling the segment growth.
 
CHEMOTHERAPY DOMINATED THE SEGMENT
By therapy, chemotherapy led the segment in 2017. Owing to an ability to kill cancerous cells or inhibiting its proliferation and maintain a normal level of lymphocytes of chemotherapy, it is driving the market growth. Also, the increased survival rate of the patients treated with chemotherapy is again fueling its demand.
 
NORTH AMERICA LED THE REGIONAL MARKET
Regionally, North America dominated the market by accounting major market share in 2017. Rise in the number of patients with cancer, growing genetic mutation, and increased expenditure has increased demand for effective treatment. This has driven the market growth from the last few years. Established healthcare infrastructure leading to the availability of advanced therapeutics has also contributed significantly to regional market growth.
 
KEY PLAYERS OF THE MARKET
AbbVie Inc., Amgen, ARIAD Pharmaceuticals, Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Genzyme Corporation, GlaxoSmithKline plc., Novartis International AG., Pfizer, and Teva Pharmaceuticals.  Companies are tending towards mergers and acquisition for development of novel therapeutics. For instance, TapImmune and Marker Therapeutics Announce Entry into Merger Agreement, Creating a Transformational Immuno-Oncology Platform.

As per this study the Global Leukemia Therapeutics Market was valued USD XX BN (by revenue) in 2019 and is anticipated to reach USD XX BN by 2026 with a CAGR of X%.
 
Leukemia is a type of cancer that mainly developed into blood tissues and occur in bone marrow.  It developed gradually and leads to the uncontrolled growth of the blood cells. Leukemia is also termed as a cancer of white blood cells but also affect red blood cells and platelets. Fever, weight loss, night sweats, enlarged liver, frequent infections, and swollen lymph nodes are some of the common symptoms of leukemia. Leukemia therapeutic includes radiation, chemotherapy, and stem cell transplantation.
 
Market Dynamics
 
Rising cases of cancer worldwide along with the innovation in drug discovery and increasing investment in R&D sector is expected to fuel the industry expansion. Further, ongoing research in molecular diagnosis and rising government investment in the healthcare sector is another major factor serving as a key driver for the market. Also, stem cells and bone marrow transplant are the emerging trends observed in the leukemia therapeutic market and projected to propel the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of leukemia therapeutics.
 
Market Segmentation
 
The broad leukemia therapeutics market has been sub-grouped into therapy and type. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Therapy
  • Chemotherapy
  • Biological Therapy
  • Radiation therapy
  • Targeted therapy
  • Other
 
By Type
  • Chronic leukemia
  • Chronic lymphatic leukemia
  • Chronic myeloid leukemia
  • Acute leukemia
  • Acute lymphatic leukemia
  • Acute myeloid leukemia
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for leukemia therapeutics in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Leukemia Therapeutics Market Share by Region (Representative Graph)
 
Global Leukemia Therapeutics Market Report
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the leukemia therapeutics market includes AbbVie Inc., Amgen, ARIAD Pharmaceuticals, Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Genzyme Corporation, GlaxoSmithKline plc., Novartis International AG., Pfizer, and Teva Pharmaceuticals. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . LEUKEMIA THERAPEUTICS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Therapy
           3.7.2 By Type
           3.7.3 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL LEUKEMIA THERAPEUTICS MARKET ANALYSIS BY THERAPY
       6.1 Overview by Therapy
       6.2 Historical and Forecast Data
       6.3 Analysis by Therapy
       6.4 Chemotherapy Market by Regions
       6.5 Biological Therapy Market by Regions
       6.6 Radiation therapy Market by Regions
       6.7 Targeted therapy Market by Regions
       6.8 Other Market by Regions
 
7 . GLOBAL LEUKEMIA THERAPEUTICS MARKET ANALYSIS BY TYPE
       7.1 Overview by Type
       7.2 Historical and Forecast Data
       7.3 Analysis by Type
       7.4 Chronic Leukemia Market by Regions
       7.5 Chronic Lymphatic Leukemia Market by Regions
       7.6 Chronic Myeloid Leukemia Market by Regions
       7.7 Acute Leukemia Market by Regions
       7.8 Acute Lymphatic Leukemia Market by Regions
       7.9 Acute Myeloid Heukemia Market by Regions
       7.10. Others Market by Regions
 
8 . GLOBAL LEUKEMIA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE LEUKEMIA THERAPEUTICS COMPANIES
       9.1. Leukemia Therapeutics Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF LEUKEMIA THERAPEUTICS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. AbbVie Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Amgen
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. ARIAD Pharmaceuticals, Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Bristol-Myers Squibb
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. F. Hoffmann-La Roche Ltd.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Genzyme Corporation
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. GlaxoSmithKline plc
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Novartis International AG
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Pfizer
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Teva Pharmaceuticals
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Therapy (USD MN)
  • Chemotherapy Market by Geography (USD MN)
  • Biological Therapy Market by Geography (USD MN)
  • Radiation therapy Market by Geography (USD MN)
  • Targeted therapy Market by Geography (USD MN)
  • Other Market by Geography (USD MN)
  • Analysis Market by Type (USD MN)
  • Chronic Leukemia Market by Geography (USD MN)
  • Chronic Lymphatic Leukemia Market by Geography (USD MN)
  • Chronic Myeloid Leukemia Market by Geography (USD MN)
  • Acute Leukemia Market by Geography (USD MN)
  • Acute Lymphatic Leukemia Market by Geography (USD MN)
  • Acute Myeloid Heukemia Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Leukemia Therapeutics Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Leukemia Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Leukemia Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapy
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Therapy (USD MN)
  • Chemotherapy Market by Geography (USD MN)
  • Biological Therapy Market by Geography (USD MN)
  • Radiation therapy Market by Geography (USD MN)
  • Targeted therapy Market by Geography (USD MN)
  • Other Market by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Chronic Leukemia Market by Geography (USD MN)
  • Chronic Lymphatic Leukemia Market by Geography (USD MN)
  • Chronic Myeloid Leukemia Market by Geography (USD MN)
  • Acute Leukemia Market by Geography (USD MN)
  • Acute Lymphatic Leukemia Market by Geography (USD MN)
  • Acute Myeloid Heukemia Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials